Clinical trials
Suspended trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
154 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 6 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 14 |
| 2020 | 12 |
| 2021 | 11 |
| 2022 | 16 |
| 2023 | 11 |
| 2024 | 17 |
| 2025 | 19 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 154 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sclnow Biotechnology Co., Ltd. | 8 |
| Sun Yat-sen University | 5 |
| Wondercel Biotech (ShenZhen) | 5 |
| Bioray Laboratories | 4 |
| Peking Union Medical College Hospital | 4 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 3 |
| Guangzhou Women and Children's Medical Center | 3 |
| Innovent Biologics (Suzhou) Co. Ltd. | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| Peking University People's Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 7 |
| Carcinoma, Hepatocellular | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Breast Neoplasms | 4 |
| COVID-19 | 4 |
| Hypertension | 4 |
| Multiple Myeloma | 4 |
| Carcinoma, Renal Cell | 3 |
| Heart Failure | 3 |
| Hypoparathyroidism | 3 |
Trials
Showing 51 to 75 of 154. Each trial links to its page on Pharma Observatory.
54 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.